Monoclonal antibody therapy

摘要

A new treatment option for canine atopic dermatitis is outlined by Lesley Hobson, CAE veterinary manager, Zoetis.Monoclonal antibody therapy is the fastest growing therapeutic area in human medicine and, in recent years, research has focused on how these therapies can be translated to animal health. Specifically, Zoetis has invested in bringing this innovative biological therapy to the treatment of canine atopic dermatitis.